WRN and cancer: Supporting this conclusion, WRN has recently been reported as a haploinsufficient tumour suppressor gene, based upon analyses of pan-cancer CNA data not examined here and experiments in lung epithelial cells36; we propose that it may also represent a therapeutic target in HGSOC.